Clinical characterization of 20 highly stable, untreated CLL patients
. | . | . | Stage . | . | . | Infective complications . | . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients . | Sex . | Age, y* . | Rai . | Binet . | Years from diagnosis . | Herpes . | Bacteria . | Concomitant neoplasia . | Serum Ig levels . | ||
| 1 | F | 53 | 0 | A | 13 | No | No | No | Low | ||
| 2 | M | 57 | I | A | 23 | No | Yes | No | Normal | ||
| 3 | M | 55 | 0 | A | 18 | No | No | Prostate adenoma | Normal | ||
| 4 | F | 52 | 0 | A | 14 | No | No | No | Normal | ||
| 5 | M | 63 | 0 | A | 10 | No | No | Prostate adenoma | NA | ||
| 6 | M | 69 | 0 | A | 12 | No | No | No | Normal | ||
| 7 | M | 68 | 0 | A | 10 | No | No | Parathyroid | Low | ||
| 8 | M | 51 | 0 | A | 10 | No | No | No | NA | ||
| 9 | F | 58 | 0 | A | 18 | No | No | No | Normal | ||
| 10 | F | 66 | I | A | 10 | Yes | Yes | No | Normal | ||
| 11 | M | 63 | I | A | 13 | No | No | No | Normal | ||
| 12 | F | 51 | I | A | 10 | No | No | Breast | Low | ||
| 13 | M | 50 | 0 | A | 10 | No | No | No | Normal | ||
| 14 | F | 56 | 0 | A | 23 | No | No | No | NA | ||
| 15 | F | 55 | 0 | A | 21 | Yes | No | No | NA | ||
| 16 | F | 63 | 0 | A | 14 | No | No | No | Normal | ||
| 17 | M | 62 | 0 | A | 10 | No | No | Parathyroid | Normal | ||
| 18 | M | 48 | 0 | A | 13 | No | No | No | Low | ||
| 19 | M | 57 | I | A | 10 | No | No | Basalioma | Normal | ||
| 20 | M | 54 | 0 | A | 12 | No | No | Colon | Normal | ||
. | . | . | Stage . | . | . | Infective complications . | . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients . | Sex . | Age, y* . | Rai . | Binet . | Years from diagnosis . | Herpes . | Bacteria . | Concomitant neoplasia . | Serum Ig levels . | ||
| 1 | F | 53 | 0 | A | 13 | No | No | No | Low | ||
| 2 | M | 57 | I | A | 23 | No | Yes | No | Normal | ||
| 3 | M | 55 | 0 | A | 18 | No | No | Prostate adenoma | Normal | ||
| 4 | F | 52 | 0 | A | 14 | No | No | No | Normal | ||
| 5 | M | 63 | 0 | A | 10 | No | No | Prostate adenoma | NA | ||
| 6 | M | 69 | 0 | A | 12 | No | No | No | Normal | ||
| 7 | M | 68 | 0 | A | 10 | No | No | Parathyroid | Low | ||
| 8 | M | 51 | 0 | A | 10 | No | No | No | NA | ||
| 9 | F | 58 | 0 | A | 18 | No | No | No | Normal | ||
| 10 | F | 66 | I | A | 10 | Yes | Yes | No | Normal | ||
| 11 | M | 63 | I | A | 13 | No | No | No | Normal | ||
| 12 | F | 51 | I | A | 10 | No | No | Breast | Low | ||
| 13 | M | 50 | 0 | A | 10 | No | No | No | Normal | ||
| 14 | F | 56 | 0 | A | 23 | No | No | No | NA | ||
| 15 | F | 55 | 0 | A | 21 | Yes | No | No | NA | ||
| 16 | F | 63 | 0 | A | 14 | No | No | No | Normal | ||
| 17 | M | 62 | 0 | A | 10 | No | No | Parathyroid | Normal | ||
| 18 | M | 48 | 0 | A | 13 | No | No | No | Low | ||
| 19 | M | 57 | I | A | 10 | No | No | Basalioma | Normal | ||
| 20 | M | 54 | 0 | A | 12 | No | No | Colon | Normal | ||
NA indicates not available
At the time of diagnosis